Stocks and InvestingStocks and Investing
Tue, June 1, 2021
Fri, May 28, 2021
Thu, May 27, 2021
Wed, May 26, 2021
Tue, May 25, 2021

Travis Steed Initiated (ABT) at Buy and Held Target at $150 on, May 25th, 2021


Published on 2024-10-27 16:46:43 - WOPRAI, Travis Steed
  Print publication without navigation


Travis Steed of Barclays, Initiated "Abbott Laboratories" (ABT) at Buy and Held Target at $150 on, May 25th, 2021.

Travis has made no other calls on ABT in the last 4 months.



There are 9 other peers that have a rating on ABT. Out of the 9 peers that are also analyzing ABT, 2 agree with Travis's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • James Mainwaring of "Atlantic Equities" Initiated at Hold and Held Target at $122 on, Thursday, April 15th, 2021
  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $115 on, Saturday, February 6th, 2021


These are the ratings of the 7 analyists that currently disagree with Travis


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $140 on, Wednesday, April 21st, 2021
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $130 on, Thursday, March 11th, 2021
  • Bob Hopkins of "B of A Securities" Maintained at Strong Buy with Increased Target to $145 on, Thursday, January 28th, 2021
  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $140 on, Thursday, January 28th, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $137 on, Thursday, January 28th, 2021
  • Marie Thibault of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $140 on, Thursday, January 28th, 2021
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Thursday, January 28th, 2021